BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  Merger Strengthens Mental Health Care Services

  Screening for Mental Health, a national non-profit that provides screenings and educational resources for mental health disorders announced that on May 1, it will officially merge with Riverside Community Care, a behavioral healthcare and human services organization.

  April 25, 2018

   · 

  3 min read
• Policy

  BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

  BioCardia®, Inc. announced the issuance of United States Patent No. 9,945,854 relating to methods of measuring therapeutic potency potential and defining dosages for autologous cell therapy.

  April 25, 2018

   · 

  4 min read
• BioCapital

  ACell®, Inc. Announces Participation in Symposium on Advanced Wound Care Spring

  ACell, Inc. today announced their participation in the 2018 Symposium on Advanced Wound Care Spring (SAWC Spring)/Wound Healing Society meeting being held April 25-29 in Charlotte, NC.

  April 25, 2018

   · 

  1 min read
• FDA

  Synlogic Receives Fast-Track Designation for SYNB1618, a Synthetic Biotic™ medicine for the Treatment of Phenylketonuria

  Synlogic announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its clinical product candidate, SYNB1618.

  April 25, 2018

   · 

  6 min read
• BioMidwest

  Walgreens Safe Medication Disposal Program Collects More Than 270 Tons of Unused Medications

  Walgreens announced its safe medication disposal program has collected and safely disposed of more than 270 tons of medications, or the equivalent of about 150 cars, since the launch of the program in 2016.

  April 25, 2018

   · 

  2 min read
• Can-Fite’s Piclidenoson Mechanism of Action in Psoriasis Published in ‘Journal of Immunology Research’

  Can-Fite BioPharma Ltd. announced the publication of a paper entitled “Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson” in the Journal of Immunology Research, a peer-reviewed, online open access journal.

  April 25, 2018

   · 

  6 min read
• Business

  Israel-based Medical Cannabis Solutions Provider, Kanabo Research, has Signed an Agreement With Constance Therapeutics From the US

  Kanabo Research announces it is entering an agreement with Constance Therapeutics, a US-based medical cannabis extraction company.

  April 25, 2018

   · 

  4 min read
• Drug Development

  Immunotherapy Clinical Trial Reveals Brain Tumor Shrinkage, Continues with Phase 3 Study

  Following successful Phase 1 clinical trials, the Toca regimen - a new immunotherapy for patients with recurrent brain cancer - has advanced to a Phase 3 study.

  April 25, 2018

   · 

  2 min read
• Job Trends

  Heska Confirms Details for Annual Meeting of Stockholders on May 3, 2018

  Heska Corporation confirmed access details for its 2018 Annual Meeting of Stockholders scheduled for 9 a.m. MT/11 a.m. ET on Thursday, May 3, 2018.

  April 25, 2018

   · 

  1 min read
• Policy

  Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

  Juniper Pharmaceuticals, Inc. announced an exclusive worldwide license agreement with Daré Bioscience for the development and commercialization of the Company’s intravaginal ring (IVR) technology platform.

  April 25, 2018

   · 

  4 min read